Scholar Rock Lands $36,000,000 Series B Financing Round

  • Feed Type
  • Date
    1/4/2016
  • Company Name
    Scholar Rock
  • Mailing Address
    620 Memorial Drive 2nd Floor Cambridge, MA 02139 USA
  • Company Description
    Scholar Rock is discovering and developing a new class of biologic therapies to selectively target dysregulated growth factors in the disease microenvironment by modulating supracellular activation, resulting in therapeutic effects specifically at the source of disease.
  • Website
    http://www.scholarrock.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $36,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    This financing recognizes the power of our supracellular activation platform to create a compelling drug pipeline in a broad array of therapeutic areas, including fibrosis, muscle disease, immuno-oncology and autoimmune disease.
  • M&A Terms
  • Venture Investor
    Fidelity Management & Research Company
  • Venture Investor
    Cormorant Asset Management
  • Venture Investor
    Polaris Partners
  • Venture Investor
    Investor
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    EcoR1 Capital Management
  • Venture Investor
    The Kraft Group

Trending on Xconomy